NAVANAPHAR Stock Overview
Engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 1/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
Navana Pharmaceuticals PLC Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ৳86.40 |
| 52 Week High | ৳118.90 |
| 52 Week Low | ৳78.30 |
| Beta | 0 |
| 11 Month Change | -2.04% |
| 3 Month Change | 0.35% |
| 1 Year Change | -12.37% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 227.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| NAVANAPHAR | BD Pharmaceuticals | BD Market | |
|---|---|---|---|
| 7D | -2.8% | -2.5% | -2.6% |
| 1Y | -12.4% | -19.5% | -21.5% |
Return vs Industry: NAVANAPHAR exceeded the BD Pharmaceuticals industry which returned -19.5% over the past year.
Return vs Market: NAVANAPHAR exceeded the BD Market which returned -21.5% over the past year.
Price Volatility
| NAVANAPHAR volatility | |
|---|---|
| NAVANAPHAR Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in BD Market | 7.4% |
| 10% least volatile stocks in BD Market | 3.6% |
Stable Share Price: NAVANAPHAR's share price has been volatile over the past 3 months.
Volatility Over Time: NAVANAPHAR's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of BD stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 4,143 | Md. Shafiq | www.navanapharma.com |
Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh and internationally. The company offers generic human health products, such as tablet, capsule, powder, cream, ointment, injection, eye and nasal drop, liquid, sachet, and oral solution; and animal health products, including vaccine, bolus, liquid, injection, water soluble powder, and premix. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh.
Navana Pharmaceuticals PLC Fundamentals Summary
| NAVANAPHAR fundamental statistics | |
|---|---|
| Market cap | ৳9.28b |
| Earnings (TTM) | ৳440.01m |
| Revenue (TTM) | ৳6.50b |
21.1x
P/E Ratio1.4x
P/S RatioIs NAVANAPHAR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NAVANAPHAR income statement (TTM) | |
|---|---|
| Revenue | ৳6.50b |
| Cost of Revenue | ৳3.51b |
| Gross Profit | ৳2.99b |
| Other Expenses | ৳2.55b |
| Earnings | ৳440.01m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.10 |
| Gross Margin | 46.02% |
| Net Profit Margin | 6.77% |
| Debt/Equity Ratio | 105.9% |
How did NAVANAPHAR perform over the long term?
See historical performance and comparison